Loomis, Sayles & Company’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-978
| Closed | -$20K | – | 576 |
|
|
2019
Q1 | $20K | Hold |
978
| – | – | ﹤0.01% | 652 |
|
|
2018
Q4 | $19K | Sell |
978
-809
| -45% | -$15.7K | ﹤0.01% | 711 |
|
|
2018
Q3 | $34K | Buy |
1,787
+233
| +15% | +$4.43K | ﹤0.01% | 638 |
|
|
2018
Q2 | $24K | Sell |
1,554
-314
| -17% | -$4.85K | ﹤0.01% | 751 |
|
|
2018
Q1 | $35K | Buy |
1,868
+97
| +5% | +$1.82K | ﹤0.01% | 646 |
|
|
2017
Q4 | $34K | Sell |
1,771
-28
| -2% | -$538 | ﹤0.01% | 669 |
|
|
2017
Q3 | $32K | Buy |
1,799
+285
| +19% | +$5.07K | ﹤0.01% | 673 |
|
|
2017
Q2 | $27K | Buy |
1,514
+269
| +22% | +$4.8K | ﹤0.01% | 708 |
|
|
2017
Q1 | $18K | Buy |
1,245
+53
| +4% | +$766 | ﹤0.01% | 773 |
|
|
2016
Q4 | $22K | Buy |
1,192
+1,072
| +893% | +$19.8K | ﹤0.01% | 764 |
|
|
2016
Q3 | $2K | Hold |
120
| – | – | ﹤0.01% | 956 |
|
|
2016
Q2 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 935 |
|